CRTO Criteo S.A.
Nasdaq · SEC CIK 1576427 · EDGAR
- Bought, last 12 months
- $348.6K 4 purchases by 2 insiders
- Sold, last 12 months
- $1.83M 22 sales by 4 insiders
- Filings on record
- 185 since 2021-10-27, latest 2026-09-02 16:02
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Damon Ryan | CLO | — | $823.9K |
| Glickman Sarah JS | CFO | — | $684.1K |
| Komasinski Michael | CEO, Dir | — | $296.7K |
| van der Kooi Frederik | Dir | $248.6K | — |
| TEUNISSEN ERNST 02494 | Dir | $100.0K | — |
| McGogney Connor | CFO | — | $20.9K |
| Jay Stefanie | Dir | — | — |
| Lalleman Marie | Dir | — | — |
| Picard Rachel | Dir | — | — |
| Balla Nathalie | Dir | — | — |
Transactions 208
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-27 | 2024-08-26 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $49.17 | -9,283 | 518.4K | -2% | -$456.4K | |
| 2024-08-27 | 2024-08-26 | CRTO | Glickman Sarah JS | CFO | S - Sale | $49.17 | -1,519 | 318.7K | -0.5% | -$74.7K | |
| 2024-07-25 | 2024-07-23 | CRTO | Glickman Sarah JS | CFO | S - Sale | $45.49 | -5,496 | 320.2K | -2% | -$250.0K | |
| 2024-05-31 | 2024-05-29 | CRTO | Damon Ryan | CLO | S - Sale | $39.42 | -21.0K | 131.5K | -14% | -$827.8K | |
| 2024-05-29 | 2024-05-28 | CRTO | Damon Ryan | CLO | S - Sale | $38.94 | -1,102 | 152.5K | -0.7% | -$42.9K | |
| 2024-05-28 | 2024-05-28 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $38.94 | -5,490 | 527.7K | -1% | -$213.8K | |
| 2024-05-24 | 2024-05-24 | CRTO | Glickman Sarah JS | CFO | S - Sale | $38.99 | -1,535 | 325.7K | -0.5% | -$59.8K | |
| 2024-05-24 | 2024-05-24 | CRTO | Damon Ryan | CLO | S - Sale | $38.99 | -946 | 153.6K | -0.6% | -$36.9K | |
| 2024-05-24 | 2024-05-24 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $38.99 | -3,894 | 533.2K | -0.7% | -$151.8K | |
| DMI | 2024-05-23 | 2024-05-13+ | CRTO | Umek Klaus | 10% | S - Sale | $36.71 | -100.8K | 1.77M | -5% | -$3.70M |
| DI | 2024-05-23 | 2024-05-14 | CRTO | Umek Klaus | 10% | P - Purchase | $37.67 | +6,000 | 1.78M | +0.3% | +$226.0K |
| 2024-05-07 | 2024-05-06 | CRTO | Damon Ryan | CLO | S - Sale | $37.12 | -21.7K | 154.6K | -12% | -$804.1K | |
| 2024-04-23 | 2024-04-23 | CRTO | Glickman Sarah JS | CFO | S - Sale | $35.40 | -5,504 | 327.2K | -2% | -$194.8K | |
| M | 2024-03-15 | 2024-03-13+ | CRTO | Clarken Megan | CEO, Dir | S - Sale | $35.00 | -21.3K | 537.1K | -4% | -$746.3K |
| 2024-03-12 | 2024-03-11 | CRTO | de Pesquidoux Hubert | Dir | A - Grant | $33.94 | +6,000 | 45.9K | +15% | +$203.6K | |
| 2024-03-05 | 2024-03-04 | CRTO | Damon Ryan | CLO | S - Sale | $32.91 | -1,974 | 176.2K | -1% | -$65.0K | |
| 2024-03-01 | 2024-03-01 | CRTO | Glickman Sarah JS | CFO | A - Grant | $0.00 | +39.7K | 332.7K | +14% | $0 | |
| 2024-03-01 | 2024-03-01 | CRTO | Damon Ryan | CLO | A - Grant | $0.00 | +33.7K | 178.2K | +23% | $0 | |
| 2024-03-01 | 2024-03-01 | CRTO | Clarken Megan | CEO, Dir | A - Grant | $0.00 | +80.8K | 558.4K | +17% | $0 | |
| M | 2024-02-26 | 2024-02-22+ | CRTO | Clarken Megan | CEO, Dir | S - Sale | $32.83 | -60.0K | 477.6K | -11% | -$1.97M |
| 2024-02-26 | 2024-02-23 | CRTO | Clarken Megan | CEO, Dir | A - Grant | $0.00 | +130.5K | 514.3K | +34% | $0 | |
| 2024-02-26 | 2024-02-23 | CRTO | Glickman Sarah JS | CFO | A - Grant | $0.00 | +53.0K | 302.7K | +21% | $0 | |
| 2024-02-26 | 2024-02-26 | CRTO | Glickman Sarah JS | CFO | S - Sale | $32.69 | -9,653 | 293.0K | -3% | -$315.6K | |
| 2024-02-26 | 2024-02-23 | CRTO | Damon Ryan | CLO | A - Grant | $0.00 | +35.3K | 152.5K | +30% | $0 | |
| 2024-02-26 | 2024-02-26 | CRTO | Damon Ryan | CLO | S - Sale | $32.69 | -7,959 | 144.5K | -5% | -$260.2K | |
| 2024-01-24 | 2024-01-23 | CRTO | Glickman Sarah JS | CFO | S - Sale | $24.74 | -3,622 | 249.7K | -1% | -$89.6K | |
| 2023-12-15 | 2023-12-12 | CRTO | Lalleman Marie | Dir | A - Grant | $24.50 | +7,000 | 32.8K | +27% | +$171.5K | |
| 2023-12-12 | 2023-12-11 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $24.70 | -3,538 | 407.2K | -0.9% | -$87.4K | |
| M | 2023-12-05 | 2023-12-01+ | CRTO | Damon Ryan | CLO | S - Sale | $24.88 | -8,804 | 122.5K | -7% | -$219.1K |
| 2023-11-28 | 2023-11-27 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $24.79 | -5,442 | 410.7K | -1% | -$134.9K | |
| 2023-11-28 | 2023-11-27 | CRTO | Damon Ryan | CLO | S - Sale | $24.79 | -1,652 | 126.0K | -1% | -$41.0K | |
| 2023-11-21 | 2023-11-15 | CRTO | WARNER JAMES | Dir | A - Grant | $24.39 | +7,300 | 34.9K | +26% | +$178.0K | |
| 2023-11-16 | 2023-11-15 | CRTO | Picard Rachel | Dir | A - Grant | $24.42 | +10.5K | 37.2K | +39% | +$256.4K | |
| M | 2023-11-13 | 2023-11-10+ | CRTO | Balla Nathalie | Dir | A - Grant | $23.38 | +5,971 | 23.8K | +34% | +$139.6K |
| 2023-11-09 | 2023-11-08 | CRTO | van der Kooi Frederik | Dir | A - Grant | $23.77 | +1,100 | 2,600 | +73% | +$26.1K | |
| 2023-11-09 | 2023-11-08 | CRTO | Mesrobian Edmond | Dir | A - Grant | $23.50 | +5,960 | 22.2K | +37% | +$140.1K | |
| M | 2023-10-25 | 2023-10-23 | CRTO | Glickman Sarah JS | CFO | S - Sale | $28.16 | -5,504 | 253.3K | -2% | -$155.0K |
| 2023-09-12 | 2023-09-11 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $28.60 | -3,570 | 416.2K | -0.9% | -$102.1K | |
| 2023-09-06 | 2023-09-05 | CRTO | Damon Ryan | CLO | S - Sale | $29.28 | -2,798 | 127.6K | -2% | -$81.9K | |
| 2023-08-31 | 2023-08-31 | CRTO | Damon Ryan | CLO | S - Sale | $29.30 | -3,500 | 130.4K | -3% | -$102.5K | |
| 2023-08-29 | 2023-08-25 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $28.50 | -5,496 | 419.7K | -1% | -$156.6K | |
| M | 2023-08-29 | 2023-08-25+ | CRTO | Damon Ryan | CLO | S - Sale | $28.91 | -8,668 | 133.9K | -6% | -$250.6K |
| 2023-08-08 | 2023-08-07 | CRTO | van der Kooi Frederik | Dir | P - Purchase | $30.45 | +1,500 | 1,500 | New | +$45.7K | |
| M | 2023-07-26 | 2023-07-24 | CRTO | Glickman Sarah JS | CFO | S - Sale | $32.63 | -5,461 | 258.8K | -2% | -$178.2K |
| 2023-06-16 | 2023-06-16 | CRTO | Lalleman Marie | Dir | S - Sale | $33.41 | -3,000 | 25.8K | -10% | -$100.2K | |
| 2023-06-14 | 2023-06-12 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $33.75 | -3,570 | 425.2K | -0.8% | -$120.5K | |
| D | 2023-06-07 | 2023-06-05 | CRTO | Balla Nathalie | Dir | M - OptEx | $18.71 | +6,095 | 23.9K | +34% | +$114.0K |
| D | 2023-06-07 | 2023-06-05 | CRTO | Balla Nathalie | Dir | S - Sale+OE | $33.50 | -6,095 | 17.8K | -26% | -$204.2K |
| M | 2023-06-07 | 2023-06-05 | CRTO | Damon Ryan | CLO | S - Sale | $33.81 | -1,976 | 142.6K | -1% | -$66.8K |
| M | 2023-05-30 | 2023-05-25 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $31.82 | -5,496 | 431.6K | -1% | -$174.9K |
| M | 2023-05-30 | 2023-05-25 | CRTO | Damon Ryan | CLO | S - Sale | $31.82 | -1,178 | 145.2K | -0.8% | -$37.5K |
| M | 2023-05-12 | 2023-05-12 | CRTO | Damon Ryan | CLO | S - Sale | $32.01 | -18.0K | 158.5K | -10% | -$577.1K |
| M | 2023-04-26 | 2023-04-24 | CRTO | Glickman Sarah JS | CFO | S - Sale | $30.27 | -5,042 | 264.3K | -2% | -$152.6K |
| M | 2023-03-14 | 2023-03-13 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $29.45 | -2,294 | 436.6K | -0.5% | -$67.6K |
| M | 2023-03-10 | 2023-03-09+ | CRTO | Clarken Megan | CEO, Dir | S - Sale | $30.77 | -102.9K | 469.4K | -18% | -$3.17M |
| DM | 2023-03-08 | 2023-03-06+ | CRTO | Balla Nathalie | Dir | M - OptEx | $19.94 | +42.0K | 40.2K | New | +$837.9K |
| DM | 2023-03-08 | 2023-03-06+ | CRTO | Balla Nathalie | Dir | S - Sale+OE | $32.34 | -42.0K | 17.8K | -70% | -$1.36M |
| M | 2023-03-03 | 2023-03-03 | CRTO | Damon Ryan | CLO | S - Sale | $32.22 | -124 | 163.8K | -0.1% | -$3,995 |
| M | 2023-03-01 | 2023-02-27 | CRTO | Damon Ryan | CLO | S - Sale | $33.64 | -25.1K | 164.2K | -13% | -$845.7K |
| M | 2023-03-01 | 2023-02-27 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $33.47 | -38.5K | 539.5K | -7% | -$1.29M |
| M | 2023-02-27 | 2023-02-23 | CRTO | Damon Ryan | CLO | A - Grant | $0.00 | +46.9K | 173.3K | +37% | $0 |
| M | 2023-02-27 | 2023-02-23 | CRTO | Glickman Sarah JS | CFO | A - Grant | $0.00 | +71.3K | 244.7K | +41% | $0 |
| 2023-02-27 | 2023-02-24 | CRTO | Picard Rachel | Dir | S - Sale | $32.52 | -10.0K | 26.7K | -27% | -$325.2K | |
| M | 2023-02-27 | 2023-02-23 | CRTO | Clarken Megan | CEO, Dir | A - Grant | $0.00 | +177.4K | 578.0K | +44% | $0 |
| D | 2023-02-15 | 2023-02-13 | CRTO | de Pesquidoux Hubert | Dir | M - OptEx | $10.34 | +10.2K | 39.9K | +34% | +$105.5K |
| M | 2023-01-24 | 2023-01-23 | CRTO | Glickman Sarah JS | CFO | S - Sale | $28.95 | -5,654 | 200.9K | -3% | -$163.7K |
| DM | 2022-12-15 | 2022-12-14 | CRTO | WARNER JAMES | Dir | M - OptEx | $10.29 | +30.6K | 37.8K | +428% | +$314.9K |
| DM | 2022-12-15 | 2022-12-14 | CRTO | WARNER JAMES | Dir | S - Sale+OE | $25.90 | -30.6K | 27.6K | -53% | -$792.5K |
| 2022-12-13 | 2022-12-12 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $26.34 | -3,645 | 400.6K | -0.9% | -$96.0K | |
| M | 2022-12-07 | 2022-12-05+ | CRTO | Picard Rachel | Dir | S - Sale | $26.90 | -12.4K | 36.7K | -25% | -$333.5K |
| M | 2022-12-06 | 2022-12-05 | CRTO | Damon Ryan | CLO | S - Sale | $27.08 | -134 | 142.3K | -0.1% | -$3,629 |
| 2022-12-02 | 2022-12-01 | CRTO | Lalleman Marie | Dir | A - Grant | $26.60 | +5,800 | 28.8K | +25% | +$154.3K | |
| 2022-12-02 | 2022-12-02 | CRTO | de Pesquidoux Hubert | Dir | A - Grant | $26.90 | +7,632 | 29.7K | +35% | +$205.3K | |
| 2022-12-01 | 2022-11-30 | CRTO | Picard Rachel | Dir | A - Grant | $26.50 | +11.4K | 49.1K | +30% | +$302.1K | |
| 2022-12-01 | 2022-11-29 | CRTO | Lalleman Marie | Dir | A - Grant | $25.90 | +666 | 23.0K | +3% | +$17.2K | |
| 2022-11-30 | 2022-11-29 | CRTO | Damon Ryan | CLO | S - Sale | $26.48 | -2,000 | 142.3K | -1% | -$53.0K | |
| 2022-11-23 | 2022-11-21 | CRTO | Balla Nathalie | Dir | A - Grant | $26.06 | +5,760 | 17.8K | +48% | +$150.1K | |
| M | 2022-11-22 | 2022-11-18+ | CRTO | Damon Ryan | CLO | S - Sale | $26.21 | -7,600 | 144.3K | -5% | -$199.2K |
| M | 2022-11-17 | 2022-11-15+ | CRTO | WARNER JAMES | Dir | A - Grant | $26.28 | +6,653 | 27.6K | +32% | +$174.9K |
| 2022-11-08 | 2022-11-07 | CRTO | Mesrobian Edmond | Dir | P - Purchase | $23.86 | +495 | 16.3K | +3% | +$11.8K | |
| 2022-11-08 | 2022-11-07 | CRTO | Mesrobian Edmond | Dir | A - Grant | $23.86 | +5,365 | 15.8K | +52% | +$128.0K | |
| 2022-10-26 | 2022-10-25 | CRTO | Damon Ryan | CLO | S - Sale | $26.37 | -40 | 151.9K | -0.0% | -$1,055 | |
| M | 2022-10-25 | 2022-10-24 | CRTO | Glickman Sarah JS | CFO | S - Sale | $26.05 | -53.7K | 203.7K | -21% | -$1.40M |
| D | 2022-10-25 | 2022-10-21 | CRTO | de Pesquidoux Hubert | Dir | M - OptEx | $8.13 | +10.4K | 22.0K | +89% | +$84.6K |
| 2022-09-13 | 2022-09-12 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $29.61 | -3,641 | 404.2K | -0.9% | -$107.8K | |
| M | 2022-09-07 | 2022-09-06 | CRTO | Damon Ryan | CLO | S - Sale | $27.36 | -134 | 152.0K | -0.1% | -$3,666 |
| 2022-08-16 | 2022-08-15 | CRTO | Damon Ryan | CLO | S - Sale | $28.57 | -15.0K | 152.1K | -9% | -$428.6K | |
| 2022-07-27 | 2022-07-25 | CRTO | Damon Ryan | CLO | S - Sale | $23.34 | -40 | 167.1K | -0.0% | -$933.60 | |
| 2022-06-14 | 2022-06-13 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $23.66 | -3,645 | 407.8K | -0.9% | -$86.2K | |
| 2022-06-03 | 2022-06-03 | CRTO | Damon Ryan | CLO | S - Sale | $26.36 | -134 | 167.2K | -0.1% | -$3,532 | |
| 2022-04-27 | 2022-04-25 | CRTO | Damon Ryan | CLO | S - Sale | $24.91 | -40 | 167.3K | -0.0% | -$996.40 | |
| 2022-03-14 | 2022-03-11 | CRTO | Clarken Megan | CEO, Dir | S - Sale | $26.37 | -2,339 | 411.5K | -0.6% | -$61.7K | |
| M | 2022-03-07 | 2022-03-03 | CRTO | Damon Ryan | EVP, Gen Counsel, Sec | S - Sale | $31.57 | -275 | 167.6K | -0.2% | -$8,682 |
| M | 2022-02-28 | 2022-02-24 | CRTO | Clarken Megan | CEO, Dir | A - Grant | $0.00 | +203.7K | 303.6K | +204% | $0 |
| M | 2022-02-28 | 2022-02-24 | CRTO | Glickman Sarah JS | CFO | A - Grant | $0.00 | +147.1K | 257.5K | +133% | $0 |
| M | 2022-02-28 | 2022-02-24 | CRTO | Damon Ryan | EVP, Gen Counsel, Sec | A - Grant | $0.00 | +49.3K | 167.6K | +42% | $0 |
| 2022-01-26 | 2022-01-25 | CRTO | Damon Ryan | EVP, Gen Counsel, Sec | S - Sale | $32.73 | -125 | 118.3K | -0.1% | -$4,091 | |
| DM | 2021-12-20 | 2021-12-16 | CRTO | Damon Ryan | EVP, Gen Counsel, Sec | S - Sale+OE | $41.01 | -10.8K | 118.4K | -8% | -$441.4K |
| D | 2021-12-20 | 2021-12-16 | CRTO | Damon Ryan | EVP, Gen Counsel, Sec | M - OptEx | $41.01 | +7,717 | 126.1K | +7% | +$316.5K |
| M | 2021-12-20 | 2021-12-17 | CRTO | de Pesquidoux Hubert | Dir | A - Grant | $40.33 | +4,349 | 11.6K | +60% | +$175.4K |
Purchase Sale Sale after option exercise All abbreviations